MBM-55 |
Inhibitor of NEK2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| NEK2 |
|
|
Inhibitor
up to 200 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - RSK1 5.4 nM, DYRK1 6.5 nM
Potency Assay Off-Target:
HTRF® KinEASE™-STK (Cisbio Assays)
Selectivity Assessment Description:
Selectivity against a panel of 11 kinases (IC50 nM): AurA 5300, AKT1 608, ABL 20, RSK1 5.4, DYRK1 ...
Potency Cellular
In Vitro
NEK2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
In Vivo Validations
Male Sprague Dawley (SD) rats
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
1.72 h
Systemic clearance:
33.3 mL/min/Kg
Reference: --
Negative Control Compounds
cpd 28a
Chemical Information
| Molecular Formula | C28H27FN6O2 |
| SMILEs | CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5cccc(F)c5)c4)cnc3c2)cn1 |
| InChI | InChI=1S/C28H27FN6O2/c1-33(2)10-11-34-17-22(15-32-34)20-8-9-35-25(16-31-27(35)14-20)21-6-7-24(28(30)36)26(13-21)37-18-19-4-3-5-23(29)12-19/h3-9,12-17H,10-11,18H2,1-2H3,(H2,30,36) |
| Molecular weight | 498.22 Da |
| AlogP | 4.2434 |
| HBond acceptors | 8 |
| HBond donors | 2 |
| Atoms | 64 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.